Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM5 | P08912 | 2/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.46 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.46 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.46 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17267038 | 1.00 | CHRM5 (0.46) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL8718336 | 1.00 | CHRM5 (0.46) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL7354189 | 1.00 | CHRM5 (0.46) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL22749079 | 1.00 | CHRM5 (0.46) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL8718338 | 1.00 | CHRM5 (0.46) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL8722900 | 1.00 | CHRM5 (0.46) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL22748785 | 1.00 | CHRM5 (0.46) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL22748767 | 1.00 | CHRM5 (0.46) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL22264510 | 1.00 | CHRM5 (0.46) | CHRM5CHRM1CHRM3CHRM2CHRM4 | |
| SCHEMBL14605529 | 1.00 | CHRM5 (0.46) | CHRM5CHRM1CHRM3CHRM2CHRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4746904-A1 | IMMUNOGENIC COMPOSITION | GlaxoSmithKline Biologicals SA (BE) | 2026-05-27 | — | — | EP | disclosed |
| EP-4747277-A1 | IMMUNOGENIC COMPOSITION | GlaxoSmithKline Biologicals SA (BE) | 2026-05-27 | — | — | EP | disclosed |
| WO-2025021712-A1 | IMMUNOGENIC COMPOSITION | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2025-01-30 | — | — | WO | disclosed |
| WO-2025021710-A1 | IMMUNOGENIC COMPOSITION | GLAXOSMITHKLINE BIOLOGICALS SA (BE) | 2025-01-30 | — | — | WO | disclosed |
| CN-105693790-A | Preparation method for full acetyl protected 2,6-dideoxy alpha-glucopyranoside | 华东师范大学 | 2016-06-22 | — | — | CN | disclosed |
| CN-105693790-A | Preparation method for full acetyl protected 2,6-dideoxy alpha-glucopyranoside | 华东师范大学 | 2016-06-22 | — | — | CN | disclosed |
| EP-0829104-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1998-03-18 | — | — | EP | disclosed |
| WO-1996035239-A1 | HIGH ENERGY DENSITY VANADIUM ELECTROLYTE SOLUTIONS, METHODS OF PREPARATION THEREOF AND ALL-VANADIUM REDOX CELLS AND BATTERIES CONTAINING HIGH ENERGY VANADIUM ELECTROLYTE SOLUTIONS | UNISEARCH LIMITED (AU) | 1996-11-07 | — | — | WO | disclosed |